2022TiP Stereotactic treatment with neoadjuvant radiotherapy and enfortumab vedotin: A phase I/II study for localized, cisplatin ineligible, muscle invasive bladder cancer (STAR-EV)
Autor: | Zhang, T., Woldu, S., Qin, Q., Cole, S., Arafat, W., Jiang, C., Wang, J., Courtney, K., DeVilbiss, A., Ploski, R., Hannan, R., Yang, D., Garant, A., Tachibana, I., Gaston, K., Wang, A.Z., Margulis, V., Lotan, Y., Desai, N. |
---|---|
Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S1165-S1165 |
Databáze: | ScienceDirect |
Externí odkaz: |